Ospedale Israelitico

The medical center is at the forefront of vitiligo research, focusing on innovative therapies that enhance skin repigmentation. The center's studies explore the combination of SCENESSE® with Narrow-Band Ultraviolet B (NB-UVB) light therapy, aiming to improve treatment outcomes for patients with vitiligo.

• SCENESSE® and NB-UVB Light Therapy
• Repigmentation Efficacy
• Safety and Tolerability

By integrating advanced phototherapy techniques, the center is pioneering new standards in vitiligo care, offering hope for enhanced skin color restoration.

Specializing in nonsegmental vitiligo, the center conducts comprehensive studies on the efficacy and safety of ritlecitinib. This research evaluates the long-term impact of varying doses, providing critical insights into the management of this chronic skin condition.

• Ritlecitinib Efficacy
• Long-term Safety
• Tolerability Studies

Through rigorous clinical trials, the center is advancing therapeutic options, aiming to improve quality of life for individuals affected by nonsegmental vitiligo.

Focusing on knee osteoarthritis, the center is engaged in cutting-edge research to assess the efficacy of intra-articular clodronate. This involves evaluating different dosing strategies to alleviate knee pain and improve joint function.

• Intra-articular Clodronate Dosing
• Pain Reduction Efficacy
• Safety and Tolerability

By exploring novel therapeutic approaches, the center aims to enhance pain management and mobility for patients suffering from knee osteoarthritis.